annual EBITDA:
-$100.97M+$702.00K(+0.69%)Summary
- As of today (September 15, 2025), TERN annual EBITDA is -$100.97 million, with the most recent change of +$702.00 thousand (+0.69%) on December 31, 2024.
- During the last 3 years, TERN annual EBITDA has fallen by -$51.63 million (-104.62%).
- TERN annual EBITDA is now -449.08% below its all-time high of -$18.39 million, reached on December 31, 2018.
Performance
TERN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$27.27M-$17.00K(-0.06%)Summary
- As of today (September 15, 2025), TERN quarterly EBITDA is -$27.27 million, with the most recent change of -$17.00 thousand (-0.06%) on June 1, 2025.
- Over the past year, TERN quarterly EBITDA has dropped by -$1.98 million (-7.82%).
- TERN quarterly EBITDA is now -214.88% below its all-time high of -$8.66 million, reached on December 31, 2020.
Performance
TERN quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$105.00M-$1.98M(-1.92%)Summary
- As of today (September 15, 2025), TERN TTM EBITDA is -$105.00 million, with the most recent change of -$1.98 million (-1.92%) on June 1, 2025.
- Over the past year, TERN TTM EBITDA has increased by +$2.31 million (+2.15%).
- TERN TTM EBITDA is now -963.73% below its all-time high of -$9.87 million, reached on December 31, 2019.
Performance
TERN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TERN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.7% | -7.8% | +2.1% |
| 3 y3 years | -104.6% | -97.4% | -98.5% |
| 5 y5 years | -44.3% | -172.8% | -259.5% |
TERN EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -104.6% | +0.7% | -97.4% | +17.3% | -98.5% | +2.1% |
| 5 y | 5-year | -175.7% | +0.7% | -214.9% | +17.3% | -275.1% | +2.1% |
| alltime | all time | -449.1% | +0.7% | -214.9% | +17.3% | -963.7% | +2.1% |
TERN EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$27.27M(+0.1%) | -$105.00M(+1.9%) |
| Mar 2025 | - | -$27.26M(+5.9%) | -$103.02M(+2.0%) |
| Dec 2024 | -$100.97M(-0.7%) | -$25.73M(+4.1%) | -$100.97M(+1.9%) |
| Sep 2024 | - | -$24.73M(-2.2%) | -$99.08M(-7.7%) |
| Jun 2024 | - | -$25.30M(+0.3%) | -$107.31M(+4.2%) |
| Mar 2024 | - | -$25.21M(+5.8%) | -$102.95M(+1.3%) |
| Dec 2023 | -$101.68M(+66.7%) | -$23.84M(-27.7%) | -$101.68M(+7.7%) |
| Sep 2023 | - | -$32.96M(+57.4%) | -$94.43M(+20.3%) |
| Jun 2023 | - | -$20.94M(-12.5%) | -$78.51M(+10.0%) |
| Mar 2023 | - | -$23.93M(+44.2%) | -$71.39M(+17.0%) |
| Dec 2022 | -$61.00M | -$16.59M(-2.6%) | -$61.00M(+4.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$17.04M(+23.3%) | -$58.17M(+10.0%) |
| Jun 2022 | - | -$13.81M(+2.0%) | -$52.89M(+6.3%) |
| Mar 2022 | - | -$13.55M(-1.6%) | -$49.77M(+0.9%) |
| Dec 2021 | -$49.35M(+34.7%) | -$13.76M(+17.0%) | -$49.35M(+11.5%) |
| Sep 2021 | - | -$11.76M(+9.9%) | -$44.25M(+36.2%) |
| Jun 2021 | - | -$10.70M(-18.5%) | -$32.48M(+2.2%) |
| Mar 2021 | - | -$13.12M(+51.5%) | -$31.78M(+13.5%) |
| Dec 2020 | -$36.63M(-47.7%) | -$8.66M(-13.4%) | -$28.00M(-4.1%) |
| Jun 2020 | - | -$10.00M(+7.1%) | -$29.20M(+52.1%) |
| Mar 2020 | - | -$9.34M(-5.4%) | -$19.21M(+94.6%) |
| Dec 2019 | -$70.00M(+280.7%) | -$9.87M | -$9.87M |
| Dec 2018 | -$18.39M | - | - |
FAQ
- What is Terns Pharmaceuticals, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Terns Pharmaceuticals, Inc.?
- What is Terns Pharmaceuticals, Inc. annual EBITDA year-on-year change?
- What is Terns Pharmaceuticals, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Terns Pharmaceuticals, Inc.?
- What is Terns Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
- What is Terns Pharmaceuticals, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Terns Pharmaceuticals, Inc.?
- What is Terns Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
What is Terns Pharmaceuticals, Inc. annual EBITDA?
The current annual EBITDA of TERN is -$100.97M
What is the all time high annual EBITDA for Terns Pharmaceuticals, Inc.?
Terns Pharmaceuticals, Inc. all-time high annual EBITDA is -$18.39M
What is Terns Pharmaceuticals, Inc. annual EBITDA year-on-year change?
Over the past year, TERN annual EBITDA has changed by +$702.00K (+0.69%)
What is Terns Pharmaceuticals, Inc. quarterly EBITDA?
The current quarterly EBITDA of TERN is -$27.27M
What is the all time high quarterly EBITDA for Terns Pharmaceuticals, Inc.?
Terns Pharmaceuticals, Inc. all-time high quarterly EBITDA is -$8.66M
What is Terns Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
Over the past year, TERN quarterly EBITDA has changed by -$1.98M (-7.82%)
What is Terns Pharmaceuticals, Inc. TTM EBITDA?
The current TTM EBITDA of TERN is -$105.00M
What is the all time high TTM EBITDA for Terns Pharmaceuticals, Inc.?
Terns Pharmaceuticals, Inc. all-time high TTM EBITDA is -$9.87M
What is Terns Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
Over the past year, TERN TTM EBITDA has changed by +$2.31M (+2.15%)